Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss

다국어 초록 (Multilingual Abstract)

Excess energy intake, without a compensatory increase of energy expenditure, leads to obesity. Several molecules are involved inenergy homeostasis regulation and new ones are being discovered constantly. Appetite regulating hormones such as ghrelin, peptidetyrosine-tyrosine and amylin or incretins such as the gastric inhibitory polypeptide have been studied extensively while othermolecules such as fibroblast growth factor 21, chemerin, irisin, secreted frizzle-related protein-4, total bile acids, and heme oxygenase-1 have been linked to energy homeostasis regulation more recently and the specific role of each one of them has not beenfully elucidated. This mini review focuses on the above mentioned molecules and discusses them in relation to their regulation bythe macronutrient composition of the diet as well as diet-induced weight loss.

참고문헌 (Reference)

• 1 le Roux CW, "appetite and food intake" 64 : 213-216, 2005
• 2 Santo MA, "Weight regain after gastric bypass : influence of gut hormones" 26 : 919-925, 2016
• 3 Kohli R, "Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids" 98 : E708-E712, 2013
• 4 Hansen TK, "Weight loss increases circulating levels of ghrelin in human obesity" 56 : 203-206, 2002
• 5 Helou N, "Variation of postprandial PYY 3-36 response following ingestion of differing macronutrient meals in obese females" 52 : 188-195, 2008
• 6 Phillips LK, "Update on incretin hormones" 1243 : E55-E74, 2011
• 7 Gao F, "Type 2 diabetes mitigation in the diabetic Goto-Kakizaki rat by elevated bile acids following a common-bile-duct surgery" 65 : 78-88, 2016
• 8 Bluher M, "Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention" 35 : 342-349, 2012
• 9 Li M, "Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance" 57 : 1526-1535, 2008
• 10 Liu J, "The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy" 64 : 380-390, 2015
• 11 Pournaras DJ, "The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control" 153 : 3613-3619, 2012
• 12 Gribble FM, "The gut endocrine system as a coordinator of postprandial nutrient homoeostasis" 71 : 456-462, 2012
• 13 Koliaki C, "The effect of ingested macronutrients on postprandial ghrelin response : a critical review of existing literature data" 2010 : 710852-, 2010
• 14 Murray CD, "The effect of different macronutrient infusions on appetite, ghrelin and peptide YY in parenterally fed patients" 25 : 626-633, 2006
• 15 Cahill F, "The association of serum total peptide YY (PYY) with obesity and body fat measures in the CODING study" 9 : e95235-, 2014
• 16 Lee MK, "The association between chemerin and homeostasis assessment of insulin resistance at baseline and after weight reduction via lifestyle modifications in young obese adults" 421 : 109-115, 2013
• 17 Wittamer V, "Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids" 198 : 977-985, 2003
• 18 Cahill F, "Serum peptide YY in response to short-term overfeeding in young men" 93 : 741-747, 2011
• 19 Stein S, "Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia" 59 : 33-37, 2010
• 20 Patti ME, "Serum bile acids are higher in humans with prior gastric bypass : potential contribution to improved glucose and lipid metabolism" 17 : 1671-1677, 2009
• 21 Nakatani H, "Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery" 58 : 1400-1407, 2009
• 22 Zhang X, "Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans" 57 : 1246-1253, 2008
• 23 Kawano Y, "Secreted antagonists of the Wnt signalling pathway" 116 (116): 2627-2634, 2003
• 24 Overduin J, "Role of the duodenum and macronutrient type in ghrelin regulation" 146 : 845-850, 2005
• 25 Tsuchiya Y, "Resistance exercise induces a greater irisin response than endurance exercise" 64 : 1042-1050, 2015
• 26 Mai K, "Relation between fibroblast growth factor-21, adiposity, metabolism, and weight reduction" 60 : 306-311, 2011
• 27 Galbraith RA, "Regulation of food intake and body weight by cobalt porphyrins in animals" 86 : 7653-7657, 1989
• 28 Moon HS, "Regulation of cell proliferation and malignant potential by irisin in endometrial, colon, thyroid and esophageal cancer cell lines" 63 : 188-193, 2014
• 29 Mussig K, "RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging study" 58 : 519-524, 2009
• 30 Garcia-Caraballo SC, "Prevention and reversal of hepatic steatosis with a high-protein diet in mice" 1832 : 685-695, 2013
• 31 Callahan HS, "Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans" 89 : 1319-1324, 2004
• 32 le Roux CW, "Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects" 90 : 1068-1071, 2005
• 33 Moran LJ, "Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome" 86 : 1603-1610, 2007
• 34 El Khoury D, "Postprandial ghrelin and PYY responses of male subjects on low carbohydrate meals to varied balancing proportions of proteins and fats" 49 : 493-500, 2010
• 35 Muller TD, "Play down protein to play up metabolism?" 124 : 3691-3693, 2014
• 36 de la Iglesia R, "Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients" 81 : 306-311, 2014
• 37 Shiiya T, "Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion" 87 : 240-244, 2002
• 38 Cummings DE, "Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery" 346 : 1623-1630, 2002
• 39 Prinz P, "Plasma bile acids show a positive correlation with body mass index and are negatively associated with cognitive restraint of eating in obese patients" 9 : 199-, 2015
• 40 Lutz TA, "Pancreatic amylin as a centrally acting satiating hormone" 6 : 181-189, 2005
• 41 Trouillot TE, "Orlistat maintains biliary lipid composition and hepatobiliary function in obese subjects undergoing moderate weight loss" 96 : 1888-1894, 2001
• 42 Wang L, "Octanoylated ghrelin attenuates angiogenesis induced by oxLDL in human coronary artery endothelial cells via the GHSR1a-mediated NF-κB pathway" 64 : 1262-1271, 2015
• 43 Mishra AK, "Obesity: an overview of possible role(s) of gut hormones, lipid sensing and gut microbiota" 65 : 48-65, 2016
• 44 Jones IR, "Obesity is associated with increased post-prandial GIP levels which are not reduced by dietary restriction and weight loss" 15 : 11-22, 1989
• 45 Fisher FM, "Obesity is a fibroblast growth factor 21(FGF21)-resistant state" 59 : 2781-2789, 2010
• 46 Michalakis K, "Obesity in the ageing man" 62 : 1341-1349, 2013
• 47 Chu AY, "Novel locus including FGF21 is associated with dietary macronutrient intake" 22 : 1895-1902, 2013
• 48 Mastaitis J, "Loss of SFRP4 alters body size, food intake, and energy expenditure in diet-induced obese male mice" 156 : 4502-4510, 2015
• 49 Crujeiras AB, "Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women" 26 : 198-207, 2014
• 50 Sumithran P, "Long-term persistence of hormonal adaptations to weight loss" 365 : 1597-1604, 2011
• 51 Terra X, "Long-term changes in leptin, chemerin and ghrelin levels following different bariatric surgery procedures: Roux-en-Y gastric bypass and sleeve gastrectomy" 23 : 1790-1798, 2013
• 52 Haluzikova D, "Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects" 21 : 1335-1342, 2013
• 53 Peterson SJ, "L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice" 49 : 1658-1669, 2008
• 54 Sumithran P, "Ketosis and appetite-mediating nutrients and hormones after weight loss" 67 : 759-764, 2013
• 55 Polyzos SA, "Irisin: a true, circulating hormone" 64 : 1611-1618, 2015
• 56 Brondani LA, "Irisin-encoding gene(FNDC5)variant is associated with changes in blood pressure and lipid profile in type 2 diabetic women but not in men" 64 : 952-957, 2015
• 57 Zhang Y, "Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling" 63 : 514-525, 2014
• 58 Huh JY, "Irisin physiology, oxidative stress, and thyroid dysfunction: what next?" 64 : 765-767, 2015
• 59 Swick AG, "Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass" 62 : 1070-1073, 2013
• 60 Moreno-Navarrete JM, "Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance" 98 : E769-E778, 2013
• 61 Huh JY, "Irisin in response to exercise in humans with and without metabolic syndrome" 100 : E453-E457, 2015
• 62 Huh JY, "Irisin in response to acute and chronic whole-body vibration exercise in humans" 63 : 918-921, 2014
• 63 Polyzos SA, "Irisin in patients with nonalcoholic fatty liver disease" 63 : 207-217, 2014
• 64 Bostrom PA, "Irisin in humans : recent advances and questions for future research" 63 : 178-180, 2014
• 65 Hofmann T, "Irisin as a muscle-derived hormone stimulating thermogenesis : a critical update" 54 : 89-100, 2014
• 66 Crujeiras AB, "Irisin : ‘fat’ or artefact" 82 : 467-474, 2015
• 67 Galbraith RA, "Intracerebroventricular administration of cobalt protoporphyrin elicits prolonged weight reduction in rats" 261 (261): R1395-R1401, 1991
• 68 Crujeiras AB, "Interplay of atherogenic factors, protein intake and betatrophin levels in obese-metabolic syndrome patients treated with hypocaloric diets" 40 : 403-410, 2016
• 69 Trevaskis JL, "Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats" 18 : 21-26, 2010
• 70 Galbraith RA, "Injection of cobalt protoporphyrin into the medial nuclei of the hypothalamus elicits weight loss" 263 (263): R805-R812, 1992
• 71 Batterham RL, "Inhibition of food intake in obese subjects by peptide YY3-36" 349 : 941-948, 2003
• 72 Bielohuby M, "Induction of ketosis in rats fed low-carbohydrate, high-fat diets depends on the relative abundance of dietary fat and protein" 300 : E65-E76, 2011
• 73 Tu TH, "Induction of heme oxygenase-1 with hemin reduces obesity-induced adipose tissue inflammation via adipose macrophage phenotype switching" 2014 : 290708-, 2014
• 74 de Mello AH, "Incretin-based therapies for obesity treatment" 64 : 967-981, 2015
• 75 Dushay J, "Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease" 139 : 456-463, 2010
• 76 Geloneze B, "Impaired incretin secretion and pancreatic dysfunction with older age and diabetes" 63 : 922-929, 2014
• 77 Tuzcu M, "Impact of chromium histidinate on high fat diet induced obesity in rats" 8 : 28-, 2011
• 78 Nishimura T, "Identification of a novel FGF, FGF-21, preferentially expressed in the liver" 1492 : 203-206, 2000
• 79 Lopez-Legarrea P, "Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects" 4 : e110-, 2014
• 80 van der Klaauw AA, "High protein intake stimulates postprandial GLP1 and PYY release" 21 : 1602-1607, 2013
• 81 Ryter SW, "Heme oxygenase-1/carbon monoxide : from basic science to therapeutic applications" 86 : 583-650, 2006
• 82 Chakrabarty A, "Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis" 9 : 372-381, 2003
• 83 Jais A, "Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man" 158 : 25-40, 2014
• 84 Cao J, "Heme oxygenase gene targeting to adipocytes attenuates adiposity and vascular dysfunction in mice fed a high-fat diet" 60 : 467-475, 2012
• 85 Elliott RM, "Glucagon-like peptide-1(7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man : acute post-prandial and 24-h secretion patterns" 138 : 159-166, 1993
• 86 Wren AM, "Ghrelin enhances appetite and increases food intake in humans" 86 : 5992-, 2001
• 87 Tanaka T, "Genome-wide metaanalysis of observational studies shows common genetic variants associated with macronutrient intake" 97 : 1395-1402, 2013
• 88 Meier JJ, "Gastric inhibitory polypeptide does not inhibit gastric emptying in humans" 286 : E621-E625, 2004
• 89 Hondares E, "Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue" 63 : 312-317, 2014
• 90 Badman MK, "Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis" 150 : 4931-4940, 2009
• 91 Cooper JA, "Factors affecting circulating levels of peptide YY in humans : a comprehensive review" 27 : 186-197, 2014
• 92 Ryan KK, "FXR is a molecular target for the effects of vertical sleeve gastrectomy" 509 : 183-188, 2014
• 93 Huh JY, "FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise" 61 : 1725-1738, 2012
• 94 Laeger T, "FGF21 is an endocrine signal of protein restriction" 124 : 3913-3922, 2014
• 95 Owen BM, "FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss" 20 : 670-677, 2014
• 96 Kharitonenkov A, "FGF-21 as a novel metabolic regulator" 115 : 1627-1635, 2005
• 97 Khoo J, "Exercise-induced weight loss is more effective than dieting for improving adipokine profile, insulin resistance, and inflammation in obese men" 25 : 566-575, 2015
• 98 Lee J, "Exendin-4 regulates lipid metabolism and fibroblast growth factor 21 in hepatic steatosis" 63 : 1041-1048, 2014
• 99 Zheng Y, "Epigallocatechin gallatemediated protection against tumor necrosis factor-α-induced monocyte chemoattractant protein-1 expression is heme oxygenase-1 dependent" 59 : 1528-1535, 2010
• 100 Dunn-Meynell AA, "Endogenous VMH amylin signaling is required for full leptin signaling and protection from diet-induced obesity" 310 : R355-R365, 2016
• 101 Sjolund K, "Endocrine cells in human intestine : an immunocytochemical study" 85 : 1120-1130, 1983
• 102 Chakaroun R, "Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity" 61 : 706-714, 2012
• 103 Buvga M, "Effects of the intragastric balloon MedSil on weight loss, fat tissue, lipid metabolism, and hormones involved in energy balance" 24 : 909-915, 2014
• 104 Tabesh M, "Effects of dietary energy density on serum adipocytokine levels in diabetic women" 45 : 834-839, 2013
• 105 Kudchodkar BJ, "Effects of acute caloric restriction on cholesterol metabolism in man" 30 : 1135-1146, 1977
• 106 Lewis HB, "Effect of reducing portion size at a compulsory meal on later energy intake, gut hormones, and appetite in overweight adults" 23 : 1362-1370, 2015
• 107 Essah PA, "Effect of macronutrient composition on postprandial peptide YY levels" 92 : 4052-4055, 2007
• 108 Reddy BS, "Effect of low-fat, high-carbohydrate, high-fiber diet on fecal bile acids and neutral sterols" 17 : 432-439, 1988
• 109 Runchey SS, "Effect of low-and high-glycemic load on circulating incretins in a randomized clinical trial" 62 : 188-195, 2013
• 110 Kim SH, "Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes" 80 : 825-833, 2014
• 111 Pfluger PT, "Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36" 92 : 583-588, 2007
• 112 Ress C, "Effect of bariatric surgery on circulating chemerin levels" 40 : 277-280, 2010
• 113 Albaugh VL, "Early increases in bile acids post Roux-en-Y gastric bypass are driven by insulin-sensitizing, secondary bile acids" 100 : E1225-E1233, 2015
• 114 Shakeri-Manesch S, "Diminished upregulation of visceral adipose heme oxygenase-1 correlates with waist-to-hip ratio and insulin resistance" 33 : 1257-1264, 2009
• 115 Eller LK, "Differential responses of circulating amylin to high-fat vs. high-carbohydrate meal in healthy men" 68 : 890-897, 2008
• 116 Edholm T, "Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis" 22 : 1191-1200, 2010
• 117 Thorning TK, "Diets with high-fat cheese, high-fat meat, or carbohydrate on cardiovascular risk markers in overweight postmenopausal women: a randomized crossover trial" 102 : 573-581, 2015
• 118 David LA, "Diet rapidly and reproducibly alters the human gut microbiome" 505 : 559-563, 2014
• 119 Park KH, "Diet quality is associated with circulating C-reactive protein but not irisin levels in humans" 63 : 233-241, 2014
• 120 Ko BJ, "Diet quality and diet patterns in relation to circulating cardiometabolic biomarkers" 35 : 484-490, 2016
• 121 Shimada T, "Des-acyl ghrelin protects microvascular endothelial cells from oxidative stress-induced apoptosis through sirtuin 1 signaling pathway" 63 : 469-474, 2014
• 122 Batterham RL, "Critical role for peptide YY in protein-mediated satiation and body-weight regulation" 4 : 223-233, 2006
• 123 Joung KE, "Cord blood irisin levels are positively correlated with birth weight in newborn infants" 64 : 1507-1514, 2015
• 124 Baka S, "Cord blood irisin at the extremes of fetal growth" 64 : 1515-1520, 2015
• 125 Mietlicki-Baase EG, "Cooperative interaction between leptin and amylin signaling in the ventral tegmental area for the control of food intake" 308 : E1116-E1122, 2015
• 126 Raymond F, "Consequences of exchanging carbohydrates for proteins in the cholesterol metabolism of mice fed a high-fat diet" 7 : e49058-, 2012
• 127 Simonen M, "Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass" 22 : 1473-1480, 2012
• 128 Gibbons C, "Comparison of postprandial profiles of ghrelin, active GLP-1, and total PYY to meals varying in fat and carbohydrate and their association with hunger and the phases of satiety" 98 : E847-E855, 2013
• 129 Stengel A, "Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity : correlation with body mass index" 39 : 125-130, 2013
• 130 Panagiotou G, "Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk" 63 : 1265-1271, 2014
• 131 Quinones M, "Circulating irisin levels are not regulated by nutritional status, obesity, or leptin levels in rodents" 2015 : 620919-, 2015
• 132 Anastasilakis AD, "Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition" 99 : 3247-3255, 2014
• 133 Samy DM, "Circulating irisin concentrations in rat models of thyroid dysfunction : effect of exercise" 64 : 804-813, 2015
• 134 Huerta AE, "Circulating irisin and glucose metabolism in overweight/obese women : effects of α-lipoic acid and eicosapentaenoic acid" 71 : 547-558, 2015
• 135 Hosick PA, "Chronic carbon monoxide treatment attenuates development of obesity and remodels adipocytes in mice fed a high-fat diet" 38 : 132-139, 2014
• 136 Csongradi E, "Chronic HO-1 induction with cobalt protoporphyrin (CoPP)treatment increases oxygen consumption, activity, heat production and lowers body weight in obese melanocortin-4 receptor-deficient mice" 36 : 244-253, 2012
• 137 Goralski KB, "Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism" 282 : 28175-28188, 2007
• 138 Aronis KN, "Chemerin levels as predictor of acute coronary events : a case-control study nested within the veterans affairs normative aging study" 63 : 760-766, 2014
• 139 Chamberland JP, "Chemerin is expressed mainly in pancreas and liver, is regulated by energy deprivation, and lacks day/night variation in humans" 169 : 453-462, 2013
• 140 Lehrke M, "Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis" 161 : 339-344, 2009
• 141 Bozaoglu K, "Chemerin is a novel adipokine associated with obesity and metabolic syndrome" 148 : 4687-4694, 2007
• 142 Sell H, "Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells" 58 : 2731-2740, 2009
• 143 Sell H, "Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery" 95 : 2892-2896, 2010
• 144 Ehrlund A, "Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs)in human adipose tissue" 98 : E503-E508, 2013
• 145 Martucci CP, "Changes in serum bile acids in normal human subjects following the adoption of a low-fat diet" 768 : 331-333, 1995
• 146 McNeil J, "Changes in leptin and peptide YY do not explain the greater-than-predicted decreases in resting energy expenditure after weight loss" 100 : E443-E452, 2015
• 147 Weiss EP, "Calorie restriction and matched weight loss from exercise : independent and additive effects on glucoregulation and the incretin system in overweight women and men" 38 : 1253-1262, 2015
• 148 Lips MA, "Calorie restriction and Roux-en-Y gastric bypass have opposing effects on circulating FGF21 in morbidly obese subjects" 81 : 862-870, 2014
• 149 Abraham NG, "CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype" 64 : 1352-1361, 2014
• 150 Elsen M, "Browning of white fat: does irisin play a role in humans?" 222 : R25-R38, 2014
• 151 Parlee SD, "Biliopancreatic diversion with duodenal switch modifies plasma chemerin in early and late post-operative periods" 23 : 1201-1208, 2015
• 152 Watanabe M, "Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation" 439 : 484-489, 2006
• 153 Jahansouz C, "Bile acids increase independently from hypocaloric restriction after bariatric surgery" 2015
• 154 Nyhlin H, "Bile acid malabsorption after intestinal bypass surgery for obesity : a comparison between jejunoileal shunt and biliointestinal bypass" 14 : 47-55, 1990
• 155 Zwirska-Korczala K, "Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome" 1 : 13-35, 2007
• 156 Sodowski K, "Basal and postprandial gut peptides affecting food intake in lean and obese pregnant women" 58 (58): 37-52, 2007
• 157 le Roux CW, "Attenuated peptide YY release in obese subjects is associated with reduced satiety" 147 : 3-8, 2006
• 158 Flint A, "Associations between postprandial insulin and blood glucose responses, appetite sensations and energy intake in normal weight and overweight individuals: a meta-analysis of test meal studies" 98 : 17-25, 2007
• 159 Pardo M, "Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index" 2014 : 857270-, 2014
• 160 Crujeiras AB, "Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients" 63 : 520-531, 2014
• 161 Polyzos SA, "An update on the validity of irisin assays and the link between irisin and hepatic metabolism" 64 : 937-942, 2015
• 162 Ludvik B, "Amylin: history and overview" 14 (14): S9-S13, 1997
• 163 Rushing PA, "Amylin: a novel action in the brain to reduce body weight" 141 : 850-853, 2000
• 164 Reda TK, "Amylin, food intake, and obesity" 10 : 1087-1091, 2002
• 165 Morley JE, "Amylin decreases food intake in mice" 12 : 865-869, 1991
• 166 Huang JY, "Adipose overexpression of heme oxygenase-1 does not protect against high fat dietinduced insulin resistance in mice" 8 : e55369-, 2013
• 167 Polyzos SA, "Adipokines in nonalcoholic fatty liver disease" 65 : 1062-1079, 2016
• 168 Tonjes A, "Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes" 5 : e13911-, 2010
• 169 Bao W, "Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus : a systematic review" 64 : 756-764, 2015
• 170 Raschke S, "Adipo-myokines : two sides of the same coin : mediators of inflammation and mediators of exercise" 2013 : 320724-, 2013
• 171 Douris N, "Adaptive changes in amino acid metabolism permit normal longevity in mice consuming a lowcarbohydrate ketogenic diet" 1852 (1852): 2056-2065, 2015
• 172 Cummings DE, "A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans" 50 : 1714-1719, 2001
• 173 Bostrom P, "A PGC1-α-dependent myokine that drives brown-fat like development of white fat and thermogenesis" 481 : 463-468, 2012